Spinomenal Strengthens Demi Gods Series with Book of Demi Gods VI Title
CSP
2 min read
37

Spinomenal Strengthens Demi Gods Series with Book of Demi Gods VI Title

November 5, 2024
0

Reading Time: 2 minutes Leading iGaming content provider Spinomenal has taken its Demi Gods series to new heights with the launch of its Book of Demi Gods VI. This Spinomenal tale takes place in the Ancient Asgardian Realm amongst golden halls and vast landscapes.

Continue Reading
CSP
1 min read
34

ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 04.11.2024

November 4, 2024
0

Reading Time: < 1 minute   ALEXANDRIA GROUP OYJ NOTIFICATION     04.11.2024 at 18:30 EET   ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 04.11.2024   Date 04.11.2024   Exchange transaction Buy   Share class ALEX   Amount 280   Average price/share 8.1500 EUR Highest

Continue Reading
CSP
1 min read
33

Fondia Plc: Share repurchase 4.11.2024

November 4, 2024
0

Reading Time: < 1 minute Fondia Plc Company release 4.11.2024 at 6.45 p.m. EET   Fondia – Acquisition of own shares 4.11.2024   Fondia Plc   First North Finland   Date 4.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 241 Average price/share, EUR 5,981120

Continue Reading
ABS Showcases Commitment to Saudi Maritime Industry at Saudi Maritime & Logistics Congress
CSP
2 min read
38

ABS Showcases Commitment to Saudi Maritime Industry at Saudi Maritime & Logistics Congress

November 4, 2024
0

Reading Time: 2 minutes ABS demonstrated its commitment to the Saudi maritime industry during the recent Saudi Maritime & Logistics Congress at the Dhahran Expo in Dammam, Saudi Arabia. The event showcased the potential of Saudi Arabia as a burgeoning hub for the maritime sector

Continue Reading
CSP
4 min read
14

Announcement from the Extraordinary General Meeting of Spermosens AB (publ)

November 4, 2024
0

Reading Time: 3 minutes Spermosens AB (“Spermosens” or the “Company”) held an Extraordinary General Meeting today, 4 November 2024. At the meeting, the shareholders approved all previously announced proposals. The decisions can be summarized as follows: The meeting resolved to reduce the share capital without

Continue Reading
CSP
3 min read
22

Greenfood AB (publ) gives notice for conditional early redemption of its notes 2021/2025

November 4, 2024
0

Reading Time: 2 minutes Greenfood AB (publ) (the “Company”) today informed the holders of its up to SEK 1,300,000,000 senior secured sustainability-linked floating rate notes 2021/2025 with ISIN SE0017072457 issued by the Company (the “Notes”) of its intention to redeem the Notes early, conditional upon the

Continue Reading
CSP
1 min read
11

Notification under Chapter 9, Section 10 of the Finnish Securities Market Act

November 4, 2024
0

Reading Time: < 1 minute Neste Corporation, Stock Exchange Release, 4 November 2024 at 7.30 p.m. (EET) Neste Corporation has today received a notification under Chapter 9, Section 10 of the Finnish Securities Market Act (FSMA). According to the notification, the aggregate holdings including financial instruments according to SMA 9:6a

Continue Reading
CSP
2 min read
21

KONE Corporation: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

November 4, 2024
0

Reading Time: 2 minutes KONE Corporation, stock exchange release, November 4, 2024 at 07:00 p.m. EET KONE Corporation: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 KONE Corporation has received an announcement from BlackRock, Inc. on November 4, 2024, in accordance with the Finnish

Continue Reading
CSP
1 min read
20

#24-378 Listing of Derivatives at NGM

November 4, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
1 min read
21

BioStock: Medivir signs new clinical trial collaboration with Eisai

November 4, 2024
0

Reading Time: < 1 minute Mon, Nov 04, 2024 16:41 CET Report this content Medivir has entered into a clinical trial collaboration and supply agreement with Eisai to evaluate its liver-targeted treatment, fostrox, in combination with lenvatinib for advanced liver cancer. This partnership

Continue Reading